Showing results (1-10 of 28) with videos related to
Sort By:
Pageof 3
International Journal of Molecular Medicine|May 5, 2005
Properties of Sindbis virus vectors produced with a chimeric split helper systemAnna Ketola, Sondra Schlesinger, Jarmo WahlforsInternational Journal of Molecular Medicine|September 12, 2006
A conditionally replicative adenovirus that codes for a TK-GFP fusion protein (Ad5Delta24TK-GFP) for evaluation of the potency of oncolytic virotherapy combined with molecular chemotherapyTanja Hakkarainen, Akseli Hemminki, David T Curiel, et al.International Journal of Molecular Medicine|May 30, 2013
Recombination of replicon and helper RNAs and the emergence of propagation-competent vectors upon Sindbis virus vector productionAnna Hyvärinen, Felicitas Yongabi, Kimmo Mäkinen, et al.International Journal of Cancer|February 6, 2003
Polyamine biosynthesis inhibition enhances HSV-1 thymidine kinase/ganciclovir-mediated cytotoxicity in tumor cellsTiina Pasanen, Anne Karppinen, Leena Alhonen, et al.International Journal of Cancer|December 31, 2005
In vivo enhancement of herpes simplex virus thymidine kinase/ganciclovir cancer gene therapy with polyamine biosynthesis inhibitionTiina Wahlfors, Tanja Hakkarainen, Juhani Jänne, et al.International Journal of Oncology|May 11, 2006
Polyamine depletion and cell cycle manipulation in combination with HSV thymidine kinase/ganciclovir cancer gene therapyTiina Wahlfors, Anne Karppinen, Juhani Jänne, et al.International Journal of Oncology|June 9, 2005
HIV-1 TAT protein transduction domain mediates enhancement of enzyme prodrug cancer gene therapy in vitro: a study with TAT-TK-GFP triple fusion constructOuti Meriläinen, Tanja Hakkarainen, Tiina Wahlfors, et al.Experimental Dermatology|June 11, 2005
Characterization of transgenic mice with the expression of phenylalanine hydroxylase and GTP cyclohydrolase I in the skinRikke Christensen, Leena Alhonen, Jarmo Wahlfors, et al.International Journal of Molecular Medicine|April 7, 2004
Osteosarcoma and chondrosarcoma as targets for virus vectors and herpes simplex virus thymidine kinase/ganciclovir gene therapyAnna Ketola, Ann-Marie Määttä, Tiina Pasanen, et al.The Journal of Gene Medicine|March 11, 2005
VP22 does not significantly enhance enzyme prodrug cancer gene therapy as a part of a VP22-HSVTk-GFP triple fusion constructTanja Hakkarainen, Tiina Wahlfors, Outi Meriläinen, et al.Pageof 3